VR Logo

Alkem Laboratories Ltd.

Add to My Investments

Healthcare | Drugs & Pharma

we think vacations are for wimps

40 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

Get the Stocks!

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 1973

Chairman: Basudeo N Singh

Managing Director: Sandeep Singh

Group: --

Listing: NSE: ALKEM, BSE: 539523

Headquarters: Mumbai, Maharashtra

Website: www.alkemlabs.com

Key Facts

Market cap: R 34,554.29 Cr

Revenue (TTM): R 8,498.35 Cr

Earnings (TTM): R 1,385.21 Cr

Cash: R 1,262.10 Cr

Total Debt: R 1,700.85 Cr

Promoters' ownership: 62.43%

Liquidity: High

52 Week range: R 1,708.00 - 3,090.00

Face value: R2.00

Shares outstanding: 11,95,65,000

10 Years Aggregate:

  • CFO: 3,153.21 Cr
  • EBITDA: 7,305.31 Cr
  • Net Profit: 6,130.43 Cr

Stock Performance

Time Period Alkem Laboratories S&P BSE Healthcare S&P BSE Mid Cap
YTD47.8746.26-3.66
1 month22.9418.537.64
3 months15.0728.6226.23
1 Year68.4854.375.46
3 Years19.8615.39-0.76
5 Years--2.334.52
10 Years--13.466.63
As on 10-Aug-2020
Year Alkem Laboratories S&P BSE Mid Cap S&P BSE Healthcare
20193.79-3.05-3.55
2018-11.42-13.31-5.89
201735.2048.130.49
20168.357.97-12.88